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Abstract
Background: Predicting bed occupancy for hospitalised patients with COVID-19 requires understanding of length
of stay (LoS) in particular bed types. LoS can vary depending on the patient’s “bed pathway” - the sequence of
transfers of individual patients between bed types during a hospital stay. In this study, we characterise these
pathways, and their impact on predicted hospital bed occupancy.
Methods: We obtained data from University College Hospital (UCH) and the ISARIC4C COVID-19 Clinical Information
Network (CO-CIN) on hospitalised patients with COVID-19 who required care in general ward or critical care (CC) beds
to determine possible bed pathways and LoS. We developed a discrete-time model to examine the implications of
using either bed pathways or only average LoS by bed type to forecast bed occupancy. We compared model-
predicted bed occupancy to publicly available bed occupancy data on COVID-19 in England between March and
August 2020.
Results: In both the UCH and CO-CIN datasets, 82% of hospitalised patients with COVID-19 only received care in
general ward beds. We identified four other bed pathways, present in both datasets: “Ward, CC, Ward”, “Ward, CC”, “CC”
and “CC, Ward”. Mean LoS varied by bed type, pathway, and dataset, between 1.78 and 13.53 days.
For UCH, we found that using bed pathways improved the accuracy of bed occupancy predictions, while only using
an average LoS for each bed type underestimated true bed occupancy. However, using the CO-CIN LoS dataset we
were not able to replicate past data on bed occupancy in England, suggesting regional LoS heterogeneities.
Conclusions: We identified five bed pathways, with substantial variation in LoS by bed type, pathway, and geography.
This might be caused by local differences in patient characteristics, clinical care strategies, or resource availability, and
suggests that national LoS averages may not be appropriate for local forecasts of bed occupancy for COVID-19.
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Background
Patients with Coronavirus disease 2019 (COVID-19) can
display a range of symptoms which vary in severity [1],
with up to one in five infections requiring hospitalisa-
tion, and up to 16% of hospitalised patients requiring in-
tensive care [2, 3]. However, hospital bed capacity is
limited; for example, there was only approximately 1
critical care bed per 10,000 inhabitants in England as of
February 2020 [4]. If demand for beds exceeds hospital
capacity, this would severely decrease the quality of
healthcare provided. This would lead to worse outcomes
for all patients who require hospitalisation, not only
those with COVID-19. Consequently, it is essential to be
able to accurately predict demand for hospital beds, both
to allow a pre-emptive scale up of capacity and to act as
a barometer for the effectiveness of upstream public
health measures [5, 6].
To prioritise resource allocation, models that can
project bed occupancy are used at the hospital, re-
gional and national level [7–12]. For COVID-19, these
models typically use predicted numbers of hospital
admissions, and two simplifying assumptions. First,
that a patient’s hospital stay occurs in only one bed
type (e.g. general ward bed or critical care bed), and
second, that the stay of each patient lasts for a fixed
period. However, these assumptions are now incon-
sistent with publicly available data showing that many
patients occupy different bed types for varying dura-
tions of stay [13].
Here, we use both hospital and national level COVID-
19 inpatient data to identify the range of “bed pathways”,
the sequence of transfers of individual patients between
bed types, for a single hospital stay. We then estimate
the length of stay (LoS) by bed type for each stage in
these pathways. Finally, we develop and apply a model
to examine the importance of using these bed pathways
for bed occupancy predictions, notably for key indicators
such as peak bed and capacity requirements over time.
Methods
All of the analyses below were conducted in R [14],
using the following packages: openxlsx [15], here [16],
dplyr [17], reshape2 [18], linelist [19], ggplot2 [20], cow-
plot [21], knitr [22], rlist [23] and mstate [24]. The code
for the bed occupancy model and bed pathways data are
available in a GitHub repository (https://github.com/
qleclerc/COVID_bed_occupancy).
Patient bed pathways
A bed pathway is the sequence of transfers of individual
patients between bed types during a hospital stay. We
considered two bed types used in acute care hospitals in
England: general ward and critical care (CC) beds. Note
that in England, CC beds include both intensive care
unit (ICU) beds and high dependency unit (HDU) beds
[13], but in other countries “CC beds” and “ICU beds”
can be equivalent terms [25]. An example of a pathway
in our analysis would be “Ward, CC”, where a patient is
admitted first to a ward bed, then transferred to a CC
bed, before being discharged or dying.
UCH
We derived patient bed pathways from two datasets.
Our first dataset was provided by University College
Hospital (UCH), a teaching hospital that is part of the
University College London Hospitals National Health
Service (NHS) Foundation Trust, and one of the desig-
nated hospitals in London for admission of patients with
COVID-19. This first dataset contains date of admission,
type of bed used and date of discharge information on
168 inpatients with COVID-19 admitted to UCH be-
tween 6th March 2020 and 17th April 2020. All of these
patients are now discharged or dead, therefore the LoS
from this dataset were uncensored. The patients are not
identifiable in this dataset, and are only associated with a
number between 1 and 168. If a patient stayed in more
than one bed type during their hospitalisation, the data-
set includes an admission date, bed type, and discharge
date for each stage.
To identify all possible bed pathways, we gathered all
recorded stages by patient, and ordered them in chrono-
logical order. For each patient, the LoS for each stage
was then estimated by taking the difference between the
admission date and discharge date, and adding 1 day
(such that a patient admitted and discharged on the
same day would have an LoS of 1). The data was
regrouped by bed pathway, and for each pathway we cal-
culated the number of stages and the proportion of total
patients following the pathway. Finally, for each stage in
each bed pathway we calculated the mean LoS and
standard deviation (s.d.) To compare these estimates
with those typically used in bed occupancy models [7–
12], we also calculated an “average LoS by bed type”,
which is the mean LoS of all stages of that bed type re-
corded across all pathways. For sensitivity, we also
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estimated median LoS and interquartile range for each
stage and pathway.
CO-CIN
The second dataset was from the ISARIC WHO CCP-
UK study (National Institute for Health Research Clin-
ical Research Network Central Portfolio Management
System ID: 14152) an ongoing prospective cohort study
in England, Scotland, Wales and Northern Ireland [13].
The dataset we used contains information from 208
acute care hospitals. We used a subset of this data, re-
stricted to patients in the COVID-19 Clinical Informa-
tion Network (CO-CIN). These were patients with
proven or high likelihood of SARS-CoV-2 infection ad-
mitted to hospital between 11th March 2020 (the date
when hospital admission policy in England changed
from admitting all known COVID-19 infected to “when
necessary”) and 19th July 2020: a total of 42,980 individ-
uals. This dataset covers 80% of all patients with
COVID-19 hospitalised in England during this period.
For the CO-CIN dataset, multi-state modelling ana-
lyses were used to estimate the time patients spent in
each bed type, before transitioning to a different type, as
well as time to discharge or in-hospital death [26, 27].
Using this, we estimate LoS for each stage in each pos-
sible bed pathway. These models account for competing
risks and censoring, as not all patients had complete
follow-up, notably because some patients were still hos-
pitalised at the end of the data collection. The number
of stages in each bed pathway, and the number of pa-
tients following each pathway were also recorded.
This resulted in a set of empiric LoS distributions, one
for each stage in each bed pathway. We drew 100,000
samples from each empiric distribution to estimate
mean LoS and s.d. for each stage. As with the dataset
from UCH, we again calculated an “average LoS by bed
type”, which is the mean LoS of all stages of that bed
type recorded across all pathways. For sensitivity, we also
estimated median LoS and interquartile range for each
stage and pathway.
International
To obtain an international comparison of the possible
types of bed pathways and the proportions of patients
going through each, we used studies collated in a sys-
tematic literature review of LoS values for patients with
COVID-19 [28]. From these studies, mostly from China,
we attempted to extract possible pathways and patient
proportions (see Supplementary Material).
Model outline
To examine the impact of using patient bed pathways
on bed occupancy forecasts, we developed a flexible
discrete-time model. This model takes as input a time
series of the number and date of observed (or forecast)
daily hospital admissions over any given period of time,
and, for each bed pathway i, the following
characteristics:
– the probability that any patient will go down this
pathway (pi, where ∑ipi = 1)
– the number of stages for each pathway i (Ni)
– an average LoS in each stage j for each pathway i
(di,j)
– a standard deviation for each LoS (si,j)
For example, the pathway “Ward, CC” contains two
stages (NW,CC = 2) with a first stage where the patient
stays in a ward bed for an average of d{W,CC},1 days and
s.d. of s{W,CC},1 days, followed by a second stage in a CC
bed for an average of d{W,CC},2 days, s.d. s{W,CC},2.
The model then proceeds as follows: on the first day
(t0) of the admission data time series, we assign a path-
way, k, to each admitted patient by sampling from all of
the possible pathways, weighted by the probabilities, p.
Then, for each patient, we randomly assign a LoS for
each of the Nk stages by sampling from a Weibull distri-
bution (commonly used to represent LoS distributions
[28]) with mean dk,j (with j in Nk) and standard deviation
sk,j, and record that a bed of the corresponding type will
be needed for that duration and for the specific time
window determined by the order of the stages. Note that
if a bed is needed for a fraction of a day, we conserva-
tively assume that it is needed for that entire day (effect-
ively rounding up the LoS to the next day). For
sensitivity, we explored the impact of using a Lognormal
instead of a Weibull distribution, and of rounding the
LoS to the nearest day instead of rounding up.
Alternatively, instead of the mean and s.d., we can
specify an empirical distribution for the LoS in each
stage of the bed pathway (which we use with CO-
CIN bed pathways data - see below). In that case, for
each pathway i and stage j, the model takes as input
a vector of values for the distribution (ai,j) and a vec-
tor of the corresponding probabilities for each value
in the distribution (ri,j). For a patient assigned to a
pathway, k, the LoS at each stage, j, is then sampled
from the values provided in akj, weighted by the
probabilities provided in rkj.
For all results, 100 simulations of the model are per-
formed, for which we report the daily mean overall bed
requirements and 95% confidence intervals (mean +/−
1.96 * standard error). For each bed type, we also calcu-
late across these 100 simulations the median time and
mean size of peak bed occupancy during the period over
which admissions are generated, alongside the interquar-
tile range (IQR) and standard deviation for peak time
and peak size respectively.
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Bed occupancy predictions
UCH
To obtain a time-series of daily hospital admissions and
bed occupancy for UCH between 6th March 2020 to 17th
April 2020, we re-used the same UCH dataset on COVID-
19 inpatients described above. To generate the admissions
time-series, we counted the earliest recorded admission
date for each patient as one hospital admission on that
date, regardless of bed type and bed pathway. Our time-
series of admissions therefore represents admissions to
hospital, rather than admissions to a specific bed type. To
generate a time-series of general ward and CC bed occu-
pancy, we looked at each bed pathway recorded for each
patient. For each stage in each pathway, we noted the hos-
pital bed type that was occupied by the patient during that
stage (general ward or CC), and recorded that one hospital
bed of that type was occupied between the beginning and
end dates for that stage.
We then compared the time-series of UCH bed occu-
pancy to model-predicted occupancy for the same
period. This serves both as a model validation step, and
an opportunity to explore the impact of patient bed
pathways as a service evaluation for which model to use
for UCH. Model-predicted occupancy for UCH was gen-
erated using the UCH hospital admissions time-series,
and either the UCH bed pathways characteristics, or the
UCH average LoS by bed type values. The UCH bed
pathways characteristics used to parameterise the model
(number of pathways, number of stages for each path-
way, bed type at each stage, and mean LoS and standard
deviation for each stage) were derived from our analysis
above (see “Methods - Patient bed pathways”). This also
applies to the average LoS by bed type estimates.
As a sensitivity analysis, we repeated this, keeping the
UCH hospital admissions time-series, but using CO-CIN
bed pathways characteristics and average LoS by bed
type, instead of the UCH equivalents.
CO-CIN
As CO-CIN covers patients across the UK, we use the
LoS estimates to predict bed occupancy at a national
level. To support this analysis, we used publicly available
data from the UK Government COVID-19 dashboard on
daily hospital admissions in England (total admissions,
not separated by bed type) between 19th March 2020
and 19th August 2020 [29]. This dashboard also pro-
vides data on bed occupancy by bed type, from 20th
March 2020 to 19th August 2020 for total occupancy
(general ward plus CC), and from 2nd April 2020 to
19th August 2020 for CC occupancy only [29]. We de-
rive the number of patients in general ward beds by sub-
tracting the CC occupancy from the total occupancy.
We then compared the time-series of England bed oc-
cupancy to model-predicted occupancy for the same
period. Model-predicted occupancy for England was
generated using the England hospital admissions time-
series, and either the CO-CIN bed pathways characteris-
tics, or the CO-CIN average LoS by bed type values. The
CO-CIN bed pathways characteristics were derived from
our analysis above (see “Methods - Patient bed path-
ways”), and provide empirical distributions from which
to sample LoS at each stage in each pathway. On the
other hand, the CO-CIN average LoS by bed type values
only rely on mean LoS and standard deviation.
As a sensitivity analysis, we repeated this, keeping the
England hospital admissions time-series, but using UCH
bed pathways characteristics and average LoS by bed
type, instead of the CO-CIN equivalents.
Regional analysis
The UK Government COVID-19 dashboard also provides
daily hospital admissions and bed occupancy for each of
the seven NHS Regions in England, and for 208 NHS
Trusts [29, 30]. We repeated the above analysis for each
NHS Region, using either the CO-CIN bed pathways char-
acteristics, or average LoS by bed type values. As this
highlighted potential heterogeneity in LoS between Re-
gions (see “Results”), we then searched for the best-fitting
LoS values for each Region. We used the average LoS by
bed type values, and allowed these to vary between NHS
Regions, while maintaining the original CO-CIN propor-
tions of patients going into either a general ward or CC
bed. We identified the best-fitting values for LoS by mini-
mising the sum of squared differences between model-
predicted bed occupancy and publicly available bed occu-
pancy data by bed type, calculated for each day available.
Similarly, we found Trust level variation and hence
searched for the best-fitting LoS values for each NHS
Trust, to determine within-NHS Region heterogeneity.
As a sensitivity analysis, we also fit the model-
predicted bed occupancy at the NHS Regions level by
adjusting the proportion of patients going to a CC bed
in each Region, while maintaining the original CO-CIN




We identified five possible bed pathways for the 168 pa-
tients with COVID-19 admitted to UCH between 6th
March 2020 and 11th April 2020 (Table 1). Most pa-
tients followed the “Ward” pathway (n = 137, 81.5%),
only staying in a ward bed during their hospitalisation at
UCH. The other patient pathways, ranked from most to
least common, were: “Ward, CC, Ward” (6.0%), “Ward,
CC” (5.3%), “CC” (4.8%) and “CC, Ward” (2.4%).
The mean LoS in a ward bed across all pathways and
all stages was 3.98 days (standard deviation (s.d.) 3.60
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days), while the mean LoS in a CC bed was 4.67 days
(s.d. 3.24). However, LoS in each bed type varied be-
tween different pathways (Table 1 and Fig. 1). The short-
est mean length of stay in a ward bed was recorded in
the “Ward, CC” pathway (1.78 days, s.d. 1.46), and the
longest was recorded in the “Ward” pathway (4.37 days,
s.d. 3.79). For CC beds, the shortest mean LoS was re-
corded in the “Ward, CC, Ward” pathway (3.54 days, s.d.
1.31), and the longest was recorded in the “Ward, CC”
pathway (6.10 days, s.d. 5.17). Median LoS and IQR
values are presented in Supplementary Table 2.
CO-CIN
We found the same five bed pathways using the CO-
CIN dataset (Table 1). Most patients followed the
“Ward” pathway (n = 29,975, 82.1%); however, the pro-
portion of patients going through the other bed path-
ways differ slightly compared to UCH: “Ward, CC,
Ward” (9.9%), “CC, Ward” (6.9%), “CC” (0.6%) and
“Ward, CC” (0.5%).
LoS estimates and standard deviations are higher for
all stages and all bed pathways in CO-CIN compared to
UCH (Table 1 and Fig. 1). Across pathways, the mean
LoS in a ward bed was 8.36 days (s.d. 10.53), and 12.31
days in a CC bed (s.d. 12.47). Again, we see variation in
LoS by bed type between pathways (Fig. 1). The shortest
mean length of stay in a ward bed was recorded in the
“Ward, CC” pathway (3.27 days, s.d. 4.32), and the
longest was recorded in the “Ward” pathway (9.08 days,
s.d. 10.19). For CC beds, the shortest mean LoS was re-
corded in the “Ward, CC” pathway (8.28 days, s.d.
12.49), and the longest was recorded in the “CC, Ward”
pathway (13.53 days, s.d. 13.22). The complete empirical
and multistate-modelled distributions for these LoS ob-
tained from the CO-CIN dataset can be seen in Supple-
mentary Figure 1. Median LoS and IQR values are
presented in Supplementary Table 2.
International
In our analysis of studies reporting length of stay, none
gave bed pathway information but 21 did give informa-
tion on the “proportion of patients ever requiring an
ICU bed” (see Supplementary Material). The weighted
mean by patient number over these was 14% (s.d. 8%)
(Supplementary Table 1). This is consistent with the ag-
gregate “proportions of patients ever requiring a CC
bed” we found in UCH (18.5%) and CO-CIN (17.9%).
Impact of patient bed pathways on predicted bed
occupancy
UCH
Model-predicted bed occupancy for UCH is similar to,
but underestimates, true occupancy (Fig. 2a-b). Using
bed pathways, compared to average LoS by bed type, re-
sulted in values closer to the data (Fig. 2a-b and Supple-
mentary Table 3). Predicted peak bed demand values
Table 1 Patient pathways and length of stay for patients with COVID-19 from University College Hospital (UCH) and the COVID-19
Clinical Information Network (CO-CIN)
Dataset Beds n Proportion Stage 1 Stage 2 Stage 3 Total
Mean s.d. Mean s.d. Mean s.d. Mean s.d.
UCH Bed pathways CC 8 0.048 4.64 2.13 / / / / 4.64 2.13
CC, Ward 4 0.024 4.35 2.69 3.15 2.43 / / 7.50 2.88
Ward 137 0.815 4.37 3.79 / / / / 4.37 3.79
Ward, CC 9 0.053 1.78 1.46 6.10 5.17 / / 7.88 5.56
Ward, CC, Ward 10 0.060 2.11 1.54 3.54 1.31 2.86 2.69 8.51 3.90
Averages by bed type CC 31 0.154 4.67 3.24 / / / / 4.67 3.24
Ward 170 0.846 3.98 3.60 / / / / 3.98 3.60
Total All 168 1 / / / / / / 4.89 4.00
CO-CIN Bed pathways CC 232 0.006 10.91 12.31 / / / / 10.91 12.31
CC, Ward 2521 0.069 13.53 13.19 7.07 12.09 / / 20.75 18.00
Ward 29,975 0.821 9.60 10.83 / / / / 9.60 10.83
Ward, CC 183 0.005 3.39 4.53 8.77 13.41 / / 12.18 14.16
Ward, CC, Ward 3603 0.099 4.10 6.44 12.25 12.15 6.90 12.07 23.32 18.27
Averages by bed type CC 6539 0.141 12.58 12.78 / / / / 12.58 12.78
Ward 39,885 0.859 8.78 10.78 / / / / 8.78 10.78
Total All 36,514 1 / / / / / / 11.69 13.23
CC critical care, n number of occurrences of that pathway (for Bed pathways), or bed type (for Averages by bed type). Note that the sum of n for the bed
pathways differs from the sum for the averages, since two stages of the same bed type in one pathway correspond to two occurrences of that bed type in the
averages. s.d.: standard deviation
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Fig. 1 The proportions of hospital admissions entering each bed pathway are similar for UCH and CO-CIN, but CO-CIN has longer length of stays
by bed type and pathway. a The proportion of hospital admissions entering each bed pathway for UCH and CO-CIN. b & c Length of stay by
stage in pathway (columns) and bed type (colour) for patients with COVID-19 from University College Hospital (UCH, b) and the COVID-19 Clinical
Information Network (CO-CIN, c). The five distinct pathways are detailed in the grey boxes on the left. Error bars indicate mean plus or minus
standard deviation, and are capped at 0 and 22
Fig. 2 Using bed pathways instead of average length of stay by bed type affects model-predicted bed occupancy. Bed occupancy at UCH and
model-predicted bed occupancy using UCH (a) average length of stay estimates or (b) bed pathways. Bed occupancy in England and model-
predicted bed occupancy using CO-CIN (c) average length of stay estimates or (d) bed pathways. Shaded area is the 95% confidence interval
from 100 model runs. Note that the time period is different between data from UCH and England
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were higher when using bed pathways compared to aver-
age LoS by bed type, and hence more accurate, by ap-
proximately 17 and 18%, for ward and CC beds
respectively (Table 2).
For ward beds, 95% of data points lie within the 95%
confidence interval of the model-predicted bed occupancy
using bed pathways, while for CC beds this value is 89%.
The median peak time in ward bed occupancy estimated
by the model is 3rd April 2020 (IQR 31st March - 3rd
April) and 31st March 2020 (IQR 30th March - 3rd April),
when using bed pathways or average LoS respectively,
while the true peak occurred on 31st March 2020 (Table
2). For the CC bed occupancy peak, these dates were 2nd
April 2020 (IQR 31st March - 4th April) and 31st March
2020 (IQR 30th March - 3rd April), when using bed path-
ways or average LoS respectively, and 31st March 2020 ac-
cording to the data (Table 2).
CO-CIN
On the other hand, model-predicted bed occupancy for
England using average LoS values from CO-CIN clearly
overestimated ward and CC bed occupancy, compared
to publicly available England hospitalisation data (Fig.
2c-d). Using bed pathways from CO-CIN instead of
average LoS by bed type again led to higher estimates of
bed occupancy, by approximately 12 and 18%, for ward
and CC beds respectively (Table 2). The median esti-
mated peak time for ward bed occupancy was 10th April
2020 when using either average LoS by bed type or bed
pathways, compared to 12th April in the data. The num-
ber of beds needed at that time predicted by the model
was approximately 27% higher than the data when using
bed pathways, or 13% when using average LoS estimates.
As for peak CC bed occupancy, the data indicated this
occurred on 12th April 2020, while the median peak
times predicted by the model were 14th April (IQR 13th
April - 15th April) and 11th April (IQR 10th April -
12th April), when using bed pathways or average LoS re-
spectively. Mean peak CC bed occupancy was approxi-
mately 57 and 33% higher compared to the data when
using bed pathways or average LoS respectively.
Heterogeneity in length of stay when predicting bed
occupancy at a regional level
To further investigate discrepancies between model-
predicted bed occupancy and data in England, we apply
the model at the NHS Regions level using the values from
CO-CIN. As at the national level, our model consistently
overestimates ward and CC bed occupancy across all Re-
gions, when using either average LoS or bed pathways, al-
though the extent of this overestimate varies between
NHS Regions (Fig. 3 & Supplementary Figure 2).
Generating model estimates for average LoS for both
bed types by fixing proportions of patients admitted to
each bed type to those in CO-CIN and fitting bed occu-
pancy for each Region separately brings the model-
predicted bed occupancy much closer to the data (Fig. 4,
Supplementary Table 4). The resulting best-fit LoS
values for ward beds are smaller in all Regions compared
to the default CO-CIN value (though still higher than
UCH values) (Table 3). Similarly, best-fit LoS values are
smaller for CC beds in all Regions compared to the CO-
CIN value, except for London. Recalculating averages for
England using these regional LoS estimates weighted by
the number of hospitalisations in each Region gives a
similar pattern: LoS of 7.62 days for ward beds and 9.31
days for CC beds, while CO-CIN values for these are re-
spectively 8.78 days and 12.58 days.
Figure 5 shows the distribution of best-fitting LoS
values for 208 NHS Trusts, grouped by NHS Region.
These boxplots indicate variations in LoS between NHS
Trusts, and therefore within NHS Regions. The best-
fitting LoS values for all the Trusts are available in the
associated GitHub repository: https://github.com/
Table 2 Peak bed occupancy predicted using bed pathways data for patients with COVID-19 from UCH and CO-CIN
Dataset LoS used Ward peak bed occupancy CC peak bed occupancy
Median peak
time





















46 3.51 31/03/20 30/04/20–03/
04/20
11 2.12










18,209 99.07 11/04/20 10/04/20–12/
04/20
3835 56.26
Data 12/04/20 N/A 16,093 N/A 12/04/20 N/A 2881 N/A
Daily hospital admissions are taken from UCH or UK Government data at the England level. Peak is defined as the earliest time at which maximum bed occupancy
is reached. Results are from 100 model runs. Date format is dd/mm/yy. CC critical care, Occ. occupancy, s.d. standard deviation




Our bed occupancy predictions were less accurate when
using a Lognormal instead of a Weibull distribution for
LoS sampling (Supplementary Figure 3, Supplementary
Table 3).
We note that using UCH LoS estimates instead of
CO-CIN to predict England bed occupancy does not im-
prove the results, as this leads to an underestimate in
bed occupancy (Supplementary Figure 4). Similarly,
using CO-CIN LoS estimates to predict UCH bed occu-
pancy leads to an overestimate in ward bed occupancy,
and an underestimate in CC bed occupancy (Supple-
mentary Figure 4).
Varying the proportion of patients requiring CC beds
instead of the LoS estimates led to a worse fit of bed occu-
pancy, although the resulting proportions were consistent
with the data (Supplementary Figure 5, Supplementary
Table 4, Supplementary Table 5).
Discretizing our LoS samples by rounding to the near-
est day instead of rounding up to the next day (i.e. ceil-
ing) naturally led to reduced bed occupancy predictions.
In the case of UCH, ceiling instead of rounding im-
proved the match to data (Supplementary Table 3).
Discussion
Summary of findings
Accurate predictions of bed capacity, staff and associated
equipment requirements in hospitals require an under-
standing of patient bed pathways and length of hospital
stay. In this work we determined that, between March
and August 2020 in England, most patients with
COVID-19 (82%) required only a ward bed, for an aver-
age of 9.08 days. The remaining patients followed one of
four other bed pathways, with lengths of stay (LoS) that
varied by pathway and bed type. Incorporating bed path-
ways improved model-predicted bed occupancy at a
local hospital level, compared to only using average LoS
values by bed type. However, analyses at the England,
NHS Regions and Trust level indicate that simply using
national LoS values, even taking into account the bed
Fig. 3 Model-predicted bed occupancy at the NHS Region level using average LoS values from CO-CIN. Full line shows true bed occupancy for
the same period according to publicly available hospitalisation data (https://coronavirus.data.gov.uk/), with the dashed line being the mean of
model output and 95% confidence interval (shaded area) from 100 model runs. CC: critical care. Results using bed pathways are qualitatively
similar (Supplementary Figure 2)
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pathways, did not generate reported regional or national
bed occupancy.
Limitations
Our results are subject to limitations, notably linked to
our model assumptions. Firstly, we chose to round-up
sampled LoS estimates to the next day instead of rounding
to the closest. In the case of UCH, this improved the fit of
the model-predicted bed occupancy to the data (Supple-
mentary Table 3), however in other settings this assump-
tion could lead to overestimating bed occupancy.
Nevertheless, we consider this to be a “safer” approach, as
it implies that a bed needed for a fraction of a day is
needed for that entire day. For capacity planning, slightly
overestimating bed occupancy will likely be preferred to
underestimating it, which could have severe consequences
Fig. 4 Model-predicted bed occupancy at the NHS Region level using average best-fit LoS values. Best-fit average LoS values were obtained by
minimising the sum of squared differences between model values and data, for each bed type and Region separately. CC: critical care. Model
outputs are mean and 95% confidence intervals (shaded region) from 100 model runs
Table 3 Best-fitting length of stay values by NHS Regions
Source of LoS values Geography Ward bed LoS (mean) CC bed LoS (mean)
CO-CIN England average 8.78 12.58
Best fit by Region East of England 7.55 9.18
London 6.97 12.64
Midlands 7.36 8.08
North East and Yorkshire 7.58 8.54
North West 8.57 8.09
South East 7.87 8.07
South West 7.85 9.22
England weighted average 7.62 9.31
The England weighted average is the average of fitted LoS values in NHS Regions weighted by the proportion of cumulative England hospitalisations that
occurred in each Region. CC critical care
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on clinical care. Secondly, we did not include a maximum
bed capacity - this could improve accuracy if reaching
limits frequently prevents patients from moving between
bed types.
Thirdly, we assume that behaviours remain constant
through time, which means that the average LoS esti-
mates and proportion of patients going through each
bed pathway do not change with time. This may not be
realistic, as hospital discharge rates could vary with time,
depending on capacity and changes in organisation.
Similarly, the proportions of patients requiring critical
care could change over time, depending on the public
health measures in place which may affect the demo-
graphics of people most likely to be infected.
Finally, we assume independence within bed pathways,
meaning that the LoS for each stage is drawn randomly,
regardless of the LoS in previous stages. In reality, there
could be a correlation between stages, where for ex-
ample patients who stay in a CC bed for longer then
need a longer recovery time in a ward bed, or vice versa.
On the data side, we are limited to making conclusions
linked to the period of data collection: many things may
now have changed for patients with COVID-19 such as
differences in discharge, clinical care and admission sta-
tus, and they may have changed during data collection.
For a single hospital, estimating this time variance with
small numbers is difficult, and we would expect stochas-
ticity to have a greater impact, which would also explain
why the model and data do not perfectly align for UCH.
Nosocomial cases could also affect length of stay esti-
mates and bed occupancy. However, we were interested
in total bed occupancy for COVID-19 patients and
hence did not exclude them from our data.
Results in context
We currently have limited published evidence on the
length of hospital stay for patients with COVID-19, and
even less on patient bed pathways: two reviews estimate
the median LoS in a CC bed for patients with COVID-
19 to be approximately 8 days [28, 31] and median total
hospital LoS to be 14 days (IQR 10–19) in China [28].
Our estimates were shorter for UCH, but similar in CO-
CIN. This could be due to right-censoring in the UCH
dataset (which only included those patients no longer in
Fig. 5 Distribution of best-fitting length of stay values by NHS Trusts, grouped by NHS Region. Best-fit average LoS values were obtained by minimising the
sum of squared differences between model values and data, for each bed type and Trust separately. For each panel, the boxes correspond to the interquartile
range (IQR) and the lines to a maximum of 1.5 times the IQR from the box limits. The centre lines in the boxes are the median. Maximum LoS is capped at 30
days. CC: critical care
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the hospital) or due to the fact that few studies with
similar conditions and healthcare settings (i.e. outside
China) were included in the above mentioned reviews.
For comparison, average LoS in a CC bed for patients
needing advanced respiratory support in England during
2018–19 is 4.9 days [32]. The conclusion that most pa-
tients received care only in a general ward bed appears
robust to international comparisons.
In the early months of the pandemic, the simplifying
assumptions made by many capacity planning tools were
necessary, as detailed data were not available on bed
pathways. The next generation of bed capacity predic-
tions tools should use patient bed pathways with local
information on length of stay. To the best of our know-
ledge, there are only three other published models avail-
able which used patient bed pathways [33–35]. The first
one used the pathways “Ward”, “Ward, ICU (not venti-
lated)”, “Ward, ICU (ventilated)”, “Ward, ICU (not venti-
lated), Ward”, “Ward, ICU (ventilated), Ward” [33].
However, the sources of the parameter values for these
pathways are unclear, and seem to partly rely on a con-
sensus of clinical experts, therefore comparisons with
our results are difficult. On the other hand, the advan-
tage of our analysis is that our code and length of stay
data are both publicly available (https://github.com/
qleclerc/COVID_bed_occupancy). As for the second
model, it focused on machine-learning methods to esti-
mate transition probabilities between the clinical states
moderate/severe and critical, and is hence not compar-
able [34]. The third model is closely aligned to our own
work here, as it uses multi-state methods to estimate
length of stay using a local hospital and a national data-
set from the UK [35]. Notably, this study investigates
length of stay variations depending on when a patient
was admitted to ICU during their hospitalisation, and
also concludes that national estimates can differ from
local ones.
Possible explanations
We found that our initial hypothesis, that the LoS distri-
bution for patients with COVID-19 should be the same
everywhere in England, was unlikely to hold true. In-
stead, we observed regional variation, of up to 2 days dif-
ferences for ward LoS and 4 days for CC LoS in the best
fitting model estimates, as well as variation by NHS
Trusts, and therefore within-NHS Regions. This could
be explained in several ways. LoS for other diseases has
been shown to vary between countries [36], and between
hospitals, even after accounting for differences in local
risk factors and demography [37].
However, the regional differences could also be due to
true differences between NHS Regions in the COVID-19
care pathway and clinical practice. They could also re-
flect variation in risk factors for COVID-19
hospitalisation and disease severity, which would affect
the proportion of patients in CC [38]. While we can in-
deed get a better fit by adjusting this (Supplementary
Figure 5), leading to a range of values (8.9–21.0%, mean
14.2%) which are consistent with our meta-analysis on
proportion of patients going to CC (mean 14.01%, s.d.
7.73%) (Supplementary Table 5), this is overall not as
successful compared to adjusting LoS (Supplementary
Table 4). These proportions are likely to be strongly age-
dependent, but variation in age distribution between Re-
gions (except London) are unlikely to be substantial
enough to drive the observed differences. On the other
hand, hospital resource availability does vary by Region:
COVID-19 case prevalence alongside case management
and bed availability may have affected bed pathways and
hence LoS. For context, there were approximately 5900
critical care beds available in England as of February
2020 [4], and 92,500 ward beds as of June 2020 [39], but
these were not evenly distributed between Regions, nor
was the COVID-19 case burden [40].
At the NHS Trust level, estimated differences in LoS
are harder to interpret. In a single region, Trusts may
form a network where each Trust fulfills a specific role,
such as specialising in the care of critically ill patients,
leading to patient flows between hospitals [41]. This
could cause the proportion of patients in CC to vary
heavily between Trusts, whilst for simplicity this value is
kept constant during our fitting process. Therefore, our
estimated LoS for each Trust obtained by fitting should
not be considered as truly representative. Instead, they
serve to show that there is likely substantial variation
not only between NHS Regions, but also within. The
exact nature of this heterogeneity must then be clarified
directly using Trust data on patients LoS.
A greater issue is likely to be inconsistency between
data definitions (such as “critical care”) and sources of
data (e.g. which Trusts are included) [29]. In the UK
Government COVID-19 dashboard, CC beds are defined
as “beds which are capable of delivering mechanical ven-
tilation” [29]. This may be more restrictive, as beds de-
livering mechanical ventilation would be ICU beds only
[42], while the CO-CIN definition of CC beds includes
both ICU and HDU beds [13]. However, as the defin-
ition uses the word “capable”, it could include HDU
beds. Altering the definition of CC beds to account for
them being potentially too restrictive would not improve
our national model estimates, as it would only further
increase the model-predicted ward occupancy, which is
already over-estimated.
Organisational implications
Our findings indicate that the majority (82%) of hospita-
lised patients with COVID-19 in England only stayed in
a general ward bed. Hospitals should plan infection
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control measures accordingly to prevent nosocomial
transmission of SARS-CoV-2.
In addition, the regional heterogeneities in length of
stay we have identified imply that, whenever possible,
hospitals should monitor local patient bed pathways and
adapt their organisation based on these, instead of rely-
ing on data at the national level. In the work presented
in this manuscript, the identification of patient pathways
and their use to improve bed occupancy predictions for
audit were greatly facilitated thanks to interdisciplinary
collaboration. We therefore recommend that other hos-
pitals should consider such collaborations to address or-
ganisational questions, especially in the context of public
health crises such as COVID-19.
Moreover, in predicting bed occupancy it is not just
the physical number of beds that needs to be measured
but also the additional resources in terms of equipment
and personnel. This organisation may vary between hos-
pitals. For example, different hospitals may have differ-
ent numbers of staff per bed [43, 44]. This again
highlights the importance of adapting hospital organisa-
tion at a local level, since national guidelines may not be
equally applicable to all hospitals.
Future work
Bed occupancy predictions crucially rely on predictions
of hospital admissions, which are difficult to produce, es-
pecially at lower levels, such as the hospital. Using local
past estimates of LoS can help narrow down uncertainty,
though a key driver will be admission prediction vari-
ability. For example, the timing of the UCH & England
peak bed occupancy were quite different. Our model
would rely on good bed admission predictions to fore-
cast bed occupancy, alongside accurate LoS values.
Without these, errors in timing of peak can result in
long tails of errors in levels of bed occupancy.
Understanding the reasons for the regional and sub-
regional heterogeneity is a key next step. Matching this
to known risk factor variation (e.g. in socio-economic
status and comorbidities) could improve our under-
standing of clinical care impact. Future work clarifying
the structure of patient bed pathways could be used to
better understand the factors that contribute to patient
outcomes, such as whether a patient is likely to die or be
discharged at the end of their hospitalisation [45].
Our model could be expanded to consider additional
resource complexity (such as staffing needs) and spare
capacity requirements, alongside exploring trigger times
for the need of future beds. This could be explored with
simple adaptations to this model. Similarly, an explor-
ation of time varying elements, such as admission & dis-
charge procedures, alongside COVID-19 prevalence
would be important.
This model structure is not linked specifically to the
English situation and hence could be adapted to any set-
ting. We found that patient bed pathways are likely to
be similar globally but further data is required on length
of stay to parameterise the bed pathways.
Conclusions
Our results emphasise the importance of local know-
ledge in predicting bed occupancy and hence capacity
planning. We found that using only average LoS by bed
types could underestimate bed occupancy at the hospital
level. There may be important underlying heterogene-
ities in LoS, which should be further investigated as they
may provide insight into the prevalence of risk factors
for COVID-19 or clinical care disparities. As cases of
COVID-19 are currently increasing again in England,
and for future epidemic preparedness, it is essential to
develop the best possible understanding of the bed path-
ways of patients with COVID-19 now, to avoid local
under- or overestimates of forecasted bed occupancy.
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